Cormedix
CRMD
$5.37
Share price
-2.72%
Change (1 day)
8.92%
Change (1 year)
Categories
Operating Margin for Cormedix (CRMD)
Operating Margin as of May 2024 (TTM): -46,305.20%
According to Cormedix's latest financial reports and stock price the company's current Operating Margin is -46,305.20%. At the end of 2021 the company had an Operating Margin of -15,429.47%.
Operating Margin history for Cormedix from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -15,429.47% | 35.72% |
| 2020 | -11,368.54% | 49.83% |
| 2019 | -7,587.87% | 21.55% |
| 2018 | -6,242.40% | -37.72% |
| 2017 | -10,023.45% | -8.85% |
| 2016 | -10,996.46% | 27.05% |
| 2015 | -8,655.37% | -19.9% |
| 2014 | -10,806.25% | -97.63% |
| 2013 | -456,426.69% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | 9.46% | -100.02% | 🇺🇸 USA |
 Utah Medical Products UTMD | 40.48% | -100.09% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 17.53% | -100.04% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.